BNP Paribas Financial Markets Purchases Shares of 65,139 TScan Therapeutics, Inc. (NASDAQ:TCRX)
BNP Paribas Financial Markets acquired a new position in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 65,139 shares of the company’s stock, valued at approximately $198,000. A number of other institutional investors and hedge funds have […]
BNP Paribas Financial Markets acquired a new position in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 65,139 shares of the company’s stock, valued at approximately $198,000. A number of other institutional investors and hedge funds have […]
